Effect of intermittent hepatic inflow occlusion with the Pringle maneuver during donor hepatectomy in adult living donor liver transplantation with right hemiliver grafts: A prospective, randomized controlled study

Liver Transplantation

Volumn 18, Issue 1, 2012, Pages 129-137

  Park, Jae Berm ^a   Joh, Jae Won ^b   Kim, Sung Joo ^b   David Kwon, Choon Hyuck ^b   Min Chun, Jae ^c   Man Kim, Jong ^b   Ik Moon, Ju ^b   Lee, Suk Koo ^b  

^a University of Ulsan College of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Kyungpook National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BASILIXIMAB; BILIRUBIN; CORTICOSTEROID; INTERLEUKIN 6; INTERLEUKIN 8; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SCATTER FACTOR; TACROBELL; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CASPASE 3; CYTOKINE; MALONALDEHYDE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLEEDING; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INTERMITTENT HEPATIC INFLOW OCCLUSION; LIVER BIOPSY; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER RESECTION; LIVER TRANSPLANTATION; LIVING DONOR LIVER TRANSPLANTATION; MALE; ORGAN DONOR; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE; BIOPSY; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; LIVER; LIVER CIRCULATION; LIVER DISEASE; LIVING DONOR; METABOLISM; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY; TRANSPLANTATION; TREATMENT OUTCOME; VASCULARIZATION;

ADULT; ALANINE TRANSAMINASE; BIOPSY; CASPASE 3; CYTOKINES; FEMALE; HEPATECTOMY; HEPATOCYTE GROWTH FACTOR; HUMANS; LIVER; LIVER CIRCULATION; LIVER DISEASES; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MALONDIALDEHYDE; MIDDLE AGED; PROSPECTIVE STUDIES; TRANSPLANTATION; TREATMENT OUTCOME;

EID: 84255177714     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22409     Document Type: Article

References (27)

1. Makuuchi M, Mori T, Gunvén P, Yamazaki S, Hasegawa H,. Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet 1987; 164: 155-158. (Pubitemid 17022541)
2. Petrowsky H, McCormack L, Trujillo M, Selzner M, Jochum W, Clavien PA,. A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection. Ann Surg 2006; 244: 921-928. (Pubitemid 44808626)
3. Gozzetti G, Mazziotti A, Grazi GL, Jovine E, Gallucci A, Gruttadauria S, et al. Liver resection without blood transfusion. Br J Surg 1995; 82: 1105-1110.
4. Man K, Fan ST, Ng IO, Lo CM, Liu CL, Wong J,. Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg 1997; 226: 704-711.
5. Clavien PA, Yadav S, Sindram D, Bentley RC,. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 2000; 232: 155-162. (Pubitemid 30616712)
6. Imamura H, Takayama T, Sugawara Y, Kokudo N, Aoki T, Kaneko J, et al. Pringle's manoeuvre in living donors. Lancet 2002; 360: 2049-2050. (Pubitemid 36026587)
7. Miller CM, Masetti M, Cautero N, DiBenedetto F, Lauro A, Romano A, et al. Intermittent inflow occlusion in living liver donors: impact on safety and remnant function. Liver Transpl 2004; 10: 244-247. (Pubitemid 38240123)
8. Cescon M, Grazi GL, Grassi A, Ravaioli M, Vetrone G, Ercolani G, et al. Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study. Liver Transpl 2006; 12: 628-635.
9. Jassem W, Fuggle SV, Cerundolo L, Heaton ND, Rela M,. Ischemic preconditioning of cadaver donor livers protects allografts following transplantation. Transplantation 2006; 81: 169-174.
10. Park JB, Kwon CH, Choi GS, Chun JM, Jung GO, Kim SJ, et al. Prolonged cold ischemic time is a risk factor for biliary strictures in duct-to-duct biliary reconstruction in living donor liver transplantation. Transplantation 2008; 86: 1536-1542.
11. Moon JI, Kwon CH, Joh JW, Jung GO, Choi GS, Park JB, et al. Safety of small-for-size grafts in adult-to-adult living donor liver transplantation using the right lobe. Liver Transpl 2010; 16: 864-869.
12. Cursio R, Gugenheim J, Ricci JE, Crenesse D, Rostagno P, Maulon L, et al. A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis. FASEB J 1999; 13: 253-261. (Pubitemid 29072402)
13. Belghiti J, Noun R, Malafosse R, Jagot P, Sauvanet A, Pierangeli F, et al. Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann Surg 1999; 229: 369-375. (Pubitemid 30191772)
14. Lau WY, Lai EC, Lau SH,. Methods of vascular control technique during liver resection: a comprehensive review. Hepatobiliary Pancreat Dis Int 2010; 9: 473-481.
15. Imamura H, Kokudo N, Sugawara Y, Sano K, Kaneko J, Takayama T, Makuuchi M,. Pringle's maneuver and selective inflow occlusion in living donor liver hepatectomy. Liver Transpl 2004; 10: 771-778. (Pubitemid 38787136)
16. Peralta C, Bulbena O, Xaus C, Prats N, Cutrin JC, Poli G, et al. Ischemic preconditioning: a defense mechanism against the reactive oxygen species generated after hepatic ischemia reperfusion. Transplantation 2002; 73: 1203-1211. (Pubitemid 34454264)
17. Rüdiger HA, Graf R, Clavien PA,. Sub-lethal oxidative stress triggers the protective effects of ischemic preconditioning in the mouse liver. J Hepatol 2003; 39: 972-977. (Pubitemid 37523768)
18. Koti RS, Seifalian AM, McBride AG, Yang W, Davidson BR,. The relationship of hepatic tissue oxygenation with nitric oxide metabolism in ischemic preconditioning of the liver. FASEB J 2002; 16: 1654-1656.
19. Rüdiger HA, Kang KJ, Sindram D, Riehle HM, Clavien PA,. Comparison of ischemic preconditioning and intermittent and continuous inflow occlusion in the murine liver. Ann Surg 2002; 235: 400-407. (Pubitemid 34183891)
20. Clavien PA, Selzner M, Rüdiger HA, Graf R, Kadry Z, Rousson V, Jochum W,. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003; 238: 843-850.
21. Barrier A, Olaya N, Chiappini F, Roser F, Scatton O, Artus C, et al. Ischemic preconditioning modulates the expression of several genes, leading to the overproduction of IL-1Ra, iNOS, and Bcl-2 in a human model of liver ischemia-reperfusion. FASEB J 2005; 19: 1617-1626. (Pubitemid 41429519)
22. Jang JH, Kang KJ, Kang Y, Lee IS, Graf R, Clavien PA,. Ischemic preconditioning and intermittent clamping confer protection against ischemic injury in the cirrhotic mouse liver. Liver Transpl 2008; 14: 980-988. (Pubitemid 352003897)
23. Franchello A, Gilbo N, David E, Ricchiuti A, Romagnoli R, Cerutti E, Salizzoni M,. Ischemic preconditioning (IP) of the liver as a safe and protective technique against ischemia/reperfusion injury (IRI). Am J Transplant 2009; 9: 1629-1639.
24. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, Taub R,. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996; 274: 1379-1383. (Pubitemid 26391463)
25. Yamada Y, Kirillova I, Peschon JJ, Fausto N,. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci U S A 1997; 94: 1441-1446. (Pubitemid 27087870)
26. Tian Y, Jochum W, Georgiev P, Moritz W, Graf R, Clavien PA,. Kupffer cell-dependent TNF-α signaling mediates injury in the arterialized small-for-size liver transplantation in the mouse. Proc Natl Acad Sci U S A 2006; 103: 4598-4603.
27. Pediaditakis P, Lopez-Talavera JC, Petersen B, Monga SP, Michalopoulos GK,. The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat. Hepatology 2001; 34 (pt 1): 688-693. (Pubitemid 32927992)